Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC (TAUC)
Sponsor: Anthony Bai
A NA clinical study on MRSA, this trial is actively recruiting participants. The trial is conducted by Anthony Bai and has accumulated 10 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Jul 2025 — Feb 2026 [monthly]
Recruiting NA
-
Apr 2025 — Jul 2025 [monthly]
Recruiting NA
-
Dec 2024 — Apr 2025 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2023 — Jul 2024 [monthly]
Recruiting NA
-
Apr 2023 — Jun 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2022 — Apr 2023 [monthly]
Not Yet Recruiting NA
-
Apr 2021 — Jun 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Anthony Bai
- Canadian Institutes of Health Research (CIHR)
- Physician Services Incorporated
For direct contact, visit the study record on ClinicalTrials.gov .